已收录 268921 条政策
 政策提纲
  • 暂无提纲
Fluconazole in the treatment of Cushing's disease
[摘要] SummaryKetoconazole was a first-line agent for suppressing steroidogenesis in Cushing's disease. It now has limited availability. Fluconazole, another azole antifungal, is an alternative, although its in vivo efficacy is unclear. A 61-year-old female pres
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 内分泌与代谢学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文